Search results for "030204 cardiovascular system & hematology"

showing 10 items of 3288 documents

Within subject variability of HDL-cholesterol in HIV-infected patients

2019

Background and objective: Within-subject variability of cardiovascular risk factors may influence the development of cardiovascular disease. We aimed to improve knowledge on HDL-cholesterol variability and its clinical significance in HIV-infected patients, a population at high risk of cardiovascular disease.Methods: This was a cohort study to quantify the variability of HDL-cholesterol between two consecutive visits and to determine factors associated with such variability, in a group of HIV-infected patients.Results: A total of 307 patients were included, mean ± standard deviation of their age was 45.1 ± 8.5 years, and 225 of them (73.3%) were male. The absolute difference (after squaring…

AdultBlood GlucoseMalemedicine.medical_specialtyAlcohol DrinkingWithin personPopulationBlood PressureHIV Infections030209 endocrinology & metabolismAbsolute difference030204 cardiovascular system & hematologyStandard deviationCigarette SmokingCohort Studies03 medical and health scienceschemistry.chemical_compoundSex Factors0302 clinical medicineHeart RateRisk FactorsInternal medicinemedicineHumansHiv infected patientsClinical significanceeducationeducation.field_of_studyCholesterolbusiness.industryCholesterol HDLAge FactorsGeneral MedicineMiddle AgedLipidsAnti-Retroviral AgentschemistryFemalelipids (amino acids peptides and proteins)businessCohort studyPostgraduate Medicine
researchProduct

Are general practitioners characteristics associated with the quality of type 2 diabetes care in general practice? Results from the Norwegian ROSA4 s…

2018

Abstract Objective: To explore the associations between general practitioners (GPs) characteristics such as gender, specialist status, country of birth and country of graduation and the quality of care for patients with type 2 diabetes (T2DM). Design: Cross-sectional survey. Setting and subjects: The 277 GPs provided care for 10082 patients with T2DM in Norway in 2014. The GPs characteristics were self-reported: 55% were male, 68% were specialists in General Practice, 82% born in Norway and 87% had graduated in Western Europe. Of patients, 81% were born in Norway and 8% in South Asia. Data regarding diabetes care were obtained from electronic medical records and manually verified. Main outc…

AdultBlood GlucoseMalemedicine.medical_specialtyAsiaCross-sectional studyGeneral PracticeEthnic groupBlood PressureNorwegian030204 cardiovascular system & hematology03 medical and health sciencesspecializationfamily medicine0302 clinical medicineGeneral Practitionersquality of careEthnicitymedicinegenderHumans030212 general & internal medicinePractice Patterns Physicians'Screening proceduresQuality of Health CareGlycated HemoglobinNorwaybusiness.industrylcsh:Public aspects of medicineMedical recordPublic Health Environmental and Occupational Healthlcsh:RA1-1270Type 2 diabetesMiddle Agedlanguage.human_languagePeer reviewEuropeCross-Sectional StudiesDiabetes Mellitus Type 2Family medicinegeneral practitionerlanguageGlobal Positioning SystemFemaleGuideline AdherencebusinessResearch ArticleGraduation
researchProduct

Insulin sensitivity and secretion and adipokine profile in patients with Cushing’s disease treated with pasireotide

2018

Purpose: To evaluate the effect of pasireotide on β-cell and adipose function in patients with Cushing’s disease (CD). Methods: Clinical and hormonal parameters, insulin secretion evaluated by HOMA-β and by the area under the curve (AUC2h) of C-peptide during a mixed meal tolerance test and insulin sensitivity, evaluated by the euglycaemic hyperinsulinaemic clamp, were evaluated in 12 patients with active CD, before and after 6 and 12 months of pasireotide. In addition, a panel of adipokines including leptin (Ob), leptin/leptin receptor ratio (Ob/Ob-R ratio), adiponectin, resistin, visfatin, adipocyte fatty acid binding protein (AFABP) and non-esterified fatty acids (NEFAs) was evaluated at…

AdultBlood GlucoseMalemedicine.medical_specialtyDiabetes mellituInjections SubcutaneousEndocrinology Diabetes and MetabolismAdipose tissueAdipokine030209 endocrinology & metabolism030204 cardiovascular system & hematologySettore MED/13 - EndocrinologiaCohort StudiesYoung Adult03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEndocrinologyAdipokinesInternal medicineDiabetes mellitusAdipokinemedicineHumansInsulinPituitary ACTH HypersecretionLeptin receptorAdiponectinbusiness.industryLeptinBody WeightMiddle AgedCushing’s diseasemedicine.diseaseInsulin sensitivityHormonesPasireotidePasireotideTreatment OutcomeEndocrinologychemistryFemaleResistinInsulin ResistanceSomatostatinbusiness
researchProduct

Once-Daily Liraglutide Versus Lixisenatide as Add-on to Metformin in Type 2 Diabetes: A 26-Week Randomized Controlled Clinical Trial

2016

OBJECTIVE To compare the efficacy and safety of liraglutide versus lixisenatide as add-on to metformin in patients with type 2 diabetes not achieving adequate glycemic control on metformin alone. RESEARCH DESIGN AND METHODS In this 26-week, randomized, parallel-group, open-label trial, 404 patients were randomized 1:1 to liraglutide 1.8 mg or lixisenatide 20 µg as add-on to metformin. Liraglutide was administered once daily at any time of the day. Lixisenatide was administered once daily within 1 h prior to the morning or evening meal. RESULTS At week 26, liraglutide reduced HbA1c (primary end point) more than lixisenatide (estimated treatment difference −0.62% [95% CI −0.8; −0.4]; P &…

AdultBlood GlucoseMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismType 2 diabetes030204 cardiovascular system & hematologyHypoglycemiaDrug Administration Schedulelaw.inventionYoung Adult03 medical and health sciencesLixisenatidechemistry.chemical_compound0302 clinical medicineRandomized controlled triallawInternal medicineInternal MedicinemedicineClinical endpointHumansHypoglycemic AgentsAgedGlycemicAged 80 and overGlycated HemoglobinAdvanced and Specialized NursingLiraglutidebusiness.industryBody WeightLiraglutideMiddle AgedPostprandial Periodmedicine.diseaseHypoglycemiaMetforminMetforminTreatment OutcomeEndocrinologyDiabetes Mellitus Type 2chemistryDrug Therapy CombinationFemalePeptidesbusinessmedicine.drugDiabetes Care
researchProduct

Long-term Leisure-time Physical Activity and Serum Metabolome

2013

Background— Long-term physical inactivity seems to cause many health problems. We studied whether persistent physical activity compared with inactivity has a global effect on serum metabolome toward reduced cardiometabolic disease risk. Methods and Results— Sixteen same-sex twin pairs (mean age, 60 years) were selected from a cohort of twin pairs on the basis of their >30-year discordance for physical activity. Persistently (≥5 years) active and inactive groups in 3 population-based cohorts (mean ages, 31–52 years) were also studied (1037 age- and sex-matched pairs). Serum metabolome was quantified by nuclear magnetic resonance spectroscopy. We used permutation analysis to estimate the …

AdultBlood GlucoseMalemedicine.medical_specialtyMultivariate statisticsAdolescentLipoproteinsPopulationPhysiologyPhysical exerciseMotor Activity030204 cardiovascular system & hematologyCohort StudiesYoung Adult03 medical and health sciencesLeisure Activities0302 clinical medicineBlood serumPhysiology (medical)Internal medicineTwins DizygoticmedicineMetabolomeHumansIsoleucineta315education030304 developmental biology2. Zero hunger0303 health scienceseducation.field_of_studybusiness.industryFatty Acidsta3141Twins Monozygoticta3121Middle AgedTwin studyEndocrinologyCohortMetabolomeFemaleCardiology and Cardiovascular MedicinebusinessCohort studyCirculation
researchProduct

Sympathovagal balance and 1-h postload plasma glucose in normoglucose tolerant hypertensive patients.

2015

AIMS: Normoglucose tolerant (NGT) subjects with a 1-h postload plasma glucose (PLPG) value ≥155 mg/dL have an increased risk of type-2 diabetes and subclinical organ damage. Heart rate variability (HRV) reflects cardiac autonomic balance, frequently impaired in course of diabetes. At this time, no data support the association between 1-h PLPG and HRV; thus, we investigated the possible association between 1-h PLPG and HRV. METHODS: We enrolled 92 never-treated hypertensive subjects (56 women, 36 men), aged 55 ± 9.8 years. During OGTT, the patients underwent electrocardiographic recordings to evaluate HRV in the time domain (SDNN). Insulin sensitivity was assessed by Matsuda index. RESULTS: …

AdultBlood GlucoseMalemedicine.medical_specialtySettore MED/09 - Medicina Internaendocrine system diseasesglucose toleranceInsulin resistance Heart rate variability Glucose tolerance Essential hypertensionEndocrinology Diabetes and Metabolismmedicine.medical_treatment030209 endocrinology & metabolism030204 cardiovascular system & hematologyEssential hypertensionAutonomic Nervous Systeminsulin resistance heart rate variability glucose tolerance essential hypertensionImpaired glucose tolerance03 medical and health sciences0302 clinical medicineEndocrinologyInsulin resistanceHeart RateInternal medicineDiabetes mellitusinsulin resistanceGlucose IntoleranceInternal MedicineMedicineHeart rate variabilityHomeostasisHumansSubclinical infectionBalance (ability)Agedbusiness.industryInsulinheart rate variabilityessential hypertensionnutritional and metabolic diseasesGeneral MedicineGlucose Tolerance TestMiddle Agedmedicine.diseaseEndocrinologyDiabetes Mellitus Type 2HypertensionCardiologyFemalebusinesshormones hormone substitutes and hormone antagonists
researchProduct

Associations of Maximal Strength and Muscular Endurance with Cardiovascular Risk Factors

2013

The aim was to study the associations of maximal strength and muscular endurance with single and clustered cardiovascular risk factors. Muscular endurance, maximal strength, cardiorespiratory fitness and waist circumference were measured in 686 young men (25±5 years). Cardiovascular risk factors (plasma glucose, serum high- and low-density lipoprotein cholesterol, triglycerides, blood pressure) were determined. The risk factors were transformed to z-scores and the mean of values formed clustered cardiovascular risk factor. Muscular endurance was inversely associated with triglycerides, s-LDL-cholesterol, glucose and blood pressure (β=-0.09 to - 0.23, p0.05), and positively with s-HDL choles…

AdultBlood GlucoseMalemedicine.medical_specialtyWaistBlood PressurePhysical Therapy Sports Therapy and Rehabilitation030204 cardiovascular system & hematologyCardiovascular Physiological PhenomenaYoung Adult03 medical and health sciences0302 clinical medicineInsulin resistanceRisk FactorsInternal medicinemedicineHumansAerobic exerciseOrthopedics and Sports MedicineMuscle StrengthRisk factorYoung adultTriglyceridesbusiness.industryCholesterol HDLCardiorespiratory fitnessCholesterol LDL030229 sport sciencesmedicine.diseaseBlood pressureEndocrinologyCardiovascular DiseasesPhysical FitnessPhysical EnduranceWaist CircumferenceMetabolic syndromebusinessInternational Journal of Sports Medicine
researchProduct

The effect of growth hormone ( GH ) replacement on blood glucose homeostasis in adult nondiabetic patients with GH deficiency: real‐life data from th…

2015

SummaryObjective To assess the effect of 4 years’ growth hormone (GH) replacement on glucose homeostasis and evaluate factors affecting glycosylated haemoglobin (HbA1c) in adults with growth hormone deficiency (GHD). Design NordiNet® International Outcome Study, a noninterventional study, monitors long-term effectiveness and safety of GH replacement [Norditropin® (somatropin), Novo Nordisk A/S] in real-life clinical practice. Patients Nondiabetic patients (n = 245) with adult-onset GHD (age ≥20 years at GH start), ≥4 years’ GH replacement and HbA1c values at baseline and 4 years were included in the analysis. Measurements Changes from baseline (∆) to 4 years in HbA1c, fasting plasma glucose…

AdultBlood GlucoseMalemedicine.medical_specialtyWaistendocrine system diseasesHormone Replacement TherapyEndocrinology Diabetes and Metabolism030209 endocrinology & metabolism030204 cardiovascular system & hematologyGrowth hormone deficiencyImpaired glucose toleranceYoung Adult03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicineDiabetes mellitusDiabetes MellitusmedicineHomeostasisHumansGlucose homeostasisYoung adultAgedAged 80 and overGlycated Hemoglobinbusiness.industrynutritional and metabolic diseasesMiddle Agedmedicine.diseaseSomatropinTreatment OutcomeEndocrinologyGrowth HormoneFemalebusinessBody mass indexClinical Endocrinology
researchProduct

A Randomized Controlled Trial of Continuous Positive Airway Pressure on Glucose Tolerance in Obese Patients with Obstructive Sleep Apnea

2014

Study objectives Obstructive sleep apnea (OSA) is associated with an increased prevalence of metabolic syndrome (MetS), even in patients with morbid obesity. Our goal was to address whether continuous positive airway pressure (CPAP) treatment improved glucose metabolism in this population. Methods A prospective randomized controlled trial was performed in severe OSA patients with morbid obesity without diabetes in two university referral hospitals. Patients received conservative (CT) versus CPAP treatment for 12 weeks. MetS components, homeostasis model assessment of insulin resistance (HOMA-IR) and oral glucose tolerance were assessed at baseline and after treatment. Results A total of 80 …

AdultBlood GlucoseMalemedicine.medical_specialtyglucose tolerancemedicine.medical_treatmentPopulationSettore MED/10 - Malattie Dell'Apparato Respiratorio030204 cardiovascular system & hematologyImpaired glucose tolerance03 medical and health sciences0302 clinical medicineInsulin resistancePhysiology (medical)Internal medicineDiabetes mellitusinsulin resistanceGlucose IntoleranceWeight LossmedicineHumansInsulinProspective StudiesContinuous positive airway pressureeducationobstructive sleep apneaMetabolic SyndromeSleep Apnea Obstructiveeducation.field_of_studyGlucose tolerance testContinuous Positive Airway Pressuremedicine.diagnostic_testbusiness.industryGlucose Tolerance TestMiddle Agedmedicine.diseaseObesity Morbidrespiratory tract diseasesSurgeryObstructive sleep apnea030228 respiratory systemFemaleNeurology (clinical)Insulin ResistanceMetabolic syndromeSleep Disordered Breathingbusinesscontinuous positive airway pressure
researchProduct

Clinical applicability and cost-effectiveness of DIABSCORE in screening for type 2 diabetes in primary care

2017

Aims: To evaluate the applicability and cost-effectiveness of a clinical risk score (DIABSCORE) to screen for type 2 diabetes in primary care patients. Methods: Multicenter cross-sectional study of 10,508 adult no previously diagnosed with diabetes, in 2 Spanish regions (Canary Islands and Valencian Community). The variables comprising DIABSCORE were age, waist to height ratio, family history of diabetes and gestational diabetes. ROC curves were obtained; the diabetes prevalences odds ratios (HbA1c >= 6.5%) between patients exposed and not exposed to DIABSCORE >= 100, and to fasting blood glucose >= 126 mg/dL were calculated. The opinions of both the professionals and the patients concernin…

AdultBlood Glucosemedicine.medical_specialtyCost effectivenessEndocrinology Diabetes and MetabolismCost-Benefit AnalysisType 2 diabetes030204 cardiovascular system & hematologyValencianCost effectiveness03 medical and health sciences0302 clinical medicineEndocrinologyPregnancyInternal medicineDiabetes mellitusInternal MedicinemedicineOdds RatioPrevalenceHumansMass Screening030212 general & internal medicineFamily historyPrimary health careWaist-to-height ratioClinic epidemiologyPrimary Health Carebusiness.industryType 2 diabetesGeneral MedicineOdds ratioMiddle Agedmedicine.diseaselanguage.human_languageGestational diabetesCross-Sectional StudiesDiabetes Mellitus Type 2ROC CurveSpainEmergency medicinelanguageScreeningFemalebusiness
researchProduct